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Abstract This investigation aimed to evaluate patient
characteristics and procedural factors associated with
abnormal nephrograms encountered on noncontrast com-
puted axial tomography (CAT) obtained 24-h after tran-
sarterial chemoembolization (TACE) for primary and
metastatic hepatic malignancies. Sixty hepatic chemoemb-
olization procedures were performed in 29 patients who had
a median age of 63 years (range 42–79). The male-to-
female ratio was 16:13. Noncontrast CAT scans were
obtained approximately 24 h after TACE as part of our
institutional protocol and were examined for persistent
renal nephrograms. These ﬁndings were compared with
clinical and procedural parameters to determine whether
there was any association with these factors or with the
occurrence of acute renal failure (ARF). Abnormally per-
sistent CAT nephrograms were observed 24 h after 28 of 60
(46.7%) TACE procedures, of which 14 (23.3%) were
persistent, bilaterally dense, global nephrograms, and 14
(23.3%) were small, wedge-shaped, and focal nephrograms.
The change in serum creatinine from baseline to 24 h was
signiﬁcantly greater (p = 0.031) in the global nephrogram
group. The presence of cirrhosis, Child-Pugh score, proce-
dure time, baseline renal insufﬁciency, and lower peripro-
cedural mean arterial blood pressure were also statistically
signiﬁcantly associated with the occurrence of bilateral
globally dense nephrograms. The procedure time was
statistically signiﬁcantly associated with the occurrence of
wedge-like focally persistent nephrograms. Global, persis-
tently dense nephrograms and wedge-shaped focally per-
sistent nephrograms are not infrequently observed after
TACE. Persistent global nephrograms can be an important
clinical indicator of ARF. The wedge nephrogram may
represent focal renal ischemia.
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Introduction
As part of our institutional protocol, a nonenhanced
abdominal computed axial tomography (CAT) scan is
obtained 24 h after transarterial chemoembolization
(TACE) for primary and metastatic hepatic malignancies.
The rationale for these CAT scans is to evaluate the tech-
nical success of the procedure: primarily to document dis-
tribution of the chemoembolization agents suspended in
ethiodol and secondarily to exclude the possibility of non-
target embolization of these agents in the mucosa of the
intestinal tract or gallbladder. On the 24-h noncontrast CAT
scans, we occasionally observe two types of unusual
nephrographic patterns: diffuse, bilateral, and globally
dense nephograms or wedge-shaped and focally dense
nephograms. The few previous descriptions of these
nephrograms in the literature suggest that the global neph-
rogram can be an indicator of acute renal failure (ARF) and
the wedge-like, segmental nephrogram may indicate focal
renal ischemia [1–6].
The purpose of this retrospective investigation was to
determine the frequency with which the global and wedge-
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detected on follow-up noncontrast CAT and to assess
whether they are associated with changes in renal function.
Furthermore, we aimed to investigate any clinical factors
associated with these ﬁndings.
Materials and Methods
Institutional Review Board approval was granted for the
retrospective review of the electronic medical records and
archived CAT and angiographic images. From 2005 to
2007, 64 consecutive TACE procedures of the liver were
performed in 30 patients. One patient and 4 CAT scans
were excluded because emergent contrast CAT scans were
required to be performed within 12 h of the TACE pro-
cedures. Our clinical material describes the ﬁndings
derived from 29 patients undergoing 60 noncontrast CAT
scans 24 h after TACE. Characteristics of the patient
population are shown in Table 1. Twenty-one hepatocel-
lular carcinomas, 4 carcinoids, 1 insulinoma, and 3 colo-
rectal carcinomas were treated, with the tumor burden
being deﬁned as the sum measurement of the tumor’s
longest diameters according to the Response Evaluation
Criteria in Solid Tumors (RECIST) guidelines [7].
Technical Procedure
Transfemoral access using a 5F vascular sheath was
obtained for all patients, and a 5F angiographic catheter
(Cobra C2 glide catheter [Terumo, Somerset, NJ] or Sim-
mons 1 Catheter [Cook, Bloomington IN]) was used for
angiography. Contrast media (CM) used were either
iohexol-350 (Omnipaque; 350 mgI/mL) or iodixanol-320
(Visipaque; 320 mgI/mL; GE Healthcare, Princeton, NJ).
The ﬁrst step was to document the arterial supply to the
liver. The mesenteric arteries were examined to visualize
any variant blood supply to the liver. The common hepatic
artery was then selected, and the catheter was placed in a
position distal to the origin of the gastroduodenal artery in
the right or left lobar artery. If a stable catheter position
was not achieved at this level, or if it was believed that the
catheter was blocking forward arterial ﬂow, or if more
selective intratumoral delivery was desired, a 2.7-F mi-
crocatheter (Renegade Hi-Flow, Boston Scientiﬁc [Natick,
MA] or Prograte [Terumo, Somerset, NJ]) and wire (.018-
inch Agility GT [Terumo] or a .016-inch Fathom [Boston
Scientiﬁc]) were used for super-selective catheterization of
the segmental vessels supplying the tumors.
After informed patient consent was obtained, TACE was
performed according to our institutional protocol as
described by Solomon et al. [8]. Brieﬂy, doxorubicin
(60 mg), mitomycin-C (10 mg), and cisplatin (100 mg)
were suspended in ethiodized oil (Ethiodol; Savage Labo-
ratories, Melville, NY) for delivery. This suspension was
agitated into a slurry. Approximately one vial of *200–
300 micron embolic agent was added (Embosphere, Bio-
sphere Medical, Rockland, Maryland), Contor SE PVA,
(Boston Scientiﬁc, Natick Massachusetts) or LC Bead
(Angiodynamics, Freemont, CA). The treatment was ter-
minated after the total dose was administered and/or near
stasis was attained in the appropriate arterial anatomy
without reﬂux. Periprocedural nausea, pain, or fever that
occurred in association with TACE was managed symp-
tomatically with antiemetics, e.g., intravenous Phenergan
25 mg (Baxter, Deerﬁeld, IL), analgesics (morphine or
patient-controlled Dilaudid [Abbott Laboratories, Abbott
Park, IL]), and/or antipyretics. Periprocedural antibiotics
(500 mg Rocephin [Hoffmann-La Roche Inc., Nutley, NJ]
and 1 g Flagyl [Pﬁzer Inc., NY]) were given. Vigorous
periprocedural hydration (e.g., 200 cc/h normal saline) was
initiated unless contraindicated, e.g., history of congestive
heart failure. Usually a total of one liter of ﬂuids is given
before and during the procedure with an additional liter
given after the procedure. If the baseline serum creatinine
(SCr) was C1.5 mg/dL, patients received 154 mEq/L
sodium bicarbonate in dextrose and H2O—prepared in the
hospital pharmacy by adding 154 mL 1000 mEq/L sodium
bicarbonate to 846 mL 5% dextrose in H2O—as a bolus of
3 mL/kg/h for 1 h before the procedure, followed by an
infusion of 1 mL/kg/h for 6 h after the procedure, in
accordance with Merten et al. [9].
If any patient experienced signs or symptoms of post-
TACE syndrome, as manifested by nausea and vomiting,
continued abdominal pain, and fever, he or she was
admitted overnight for continued observation. If symptoms
persisted, the patients remained hospitalized until symp-
toms improved and they were believed to be clinically
stable, thus warranting discharge. Each patient was closely
monitored, which entailed additional laboratory testing,
including a 48-h serum creatinine determination.
Table 1 Summary of patient demographics
Characteristic n
Patients 29
Procedures 60
Average age ± SD (y) 62 ± 10
Median/range age (y) 63/42–79
M/F 16/13
Indication for TACE
HCC 21
CRC 3
Insulinoma 1
Carcinoid 4
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123Noncontrast 24-h CAT Image Acquisition and Renal
Attenuation Analysis
Approximately 24 h after TACE, noncontrast helical CAT
was acquired using a Light Speed 16-slice multi-detector
CAT scanner (MDCT; General Electric, Milwaukee, WI).
Imaging parameters included a large ﬁeld of view, 5-mm
slice thickness, 5-mm increment, and collimation of
20 mm, with scans performed at 100–300 mAs and 120 kV.
These unenhanced CAT scans were performed to document
iodized oil distribution and exclude nontarget localization
of the embolizing agent.
These 24-h noncontrast CAT scans were retrospectively
reviewed for the presence or absence of renal nephrograms
by one of the investigators (RWK), who has [30 years
experience as a genitourinary radiologist and was blinded
from the clinical parameters. Typically, there is no visible
renal nephrogram of either the right or left kidney at 24 h
after TACE, nor is it possible to delineate the cortex from
the medulla. In these patients, the renal parenchyma on the
24-h noncontrast CAT scans was compared with each
subject’s most recent baseline noncontrast CAT scan
(Fig. 1A). Circular regions of interest (ROIs) of the mid-
renal parenchyma were acquired from the baseline scan,
and equivalent ROIs were acquired from 24-h post-TACE
nonenhanced CAT scans. In these subjects, we compared
the parenchymal values of the right kidney with those of
the left kidney in each scan to determine if there was any
signiﬁcant difference. If there was no signiﬁcant differ-
ence, the right and left parenchymal values could be
combined into one data set of renal parenchymal values,
termed the ‘‘expected’’ 24-h noncontrast CAT scans.
Two unusual distinct but different patterns of delayed
nephrograms were encountered: (1) either bilateral and
globally dense with or without cortical and medullary dis-
crimination (‘‘global’’ group) (Fig. 1B) or (2) with focal and
wedge-shaped persistent areas of increased attenuation
(‘‘focal’’ group) (Fig. 2A, B). In cases of globally dense,
bilateral nephrograms, in which there was visual distinction
of the cortex and medulla, ROIs were acquired separately
from the cortical and medullary regions. This was encoun-
tered in the majority (14 of 16 [87.5%]) of cases. Otherwise,
single ROIs of a large region of the parenchyma were
obtained.Forcasesinwhichthecortexandmedullacouldbe
distinguished, we compared right with left renal attenuation
values of cortex to cortex, and medulla to medulla, to
determine if right and left kidneys could be combined.
The focal, wedge-shaped nephrograms were recorded as
being present or absent. If present, we tabulated whether
the wedge-shaped nephrogram was single or multiple and
unilateral or bilateral. Because the unaffected regions of
the parenchyma were visually similar, we determined
whether the right and left kidneys could be combined. We
then examined whether the combined right and left ‘‘focal’’
data set values could be combined with the ‘‘expected’’
parenchymal attenuation data set. Vicarious excretion of
CM on the 24-h noncontrast CAT scans was deﬁned as the
identiﬁcation of ﬂuid of increased attenuation within the
gallbladder lumen (Fig. 1B).
Clinical Assessment
Retrospectivereviewofthemedicalrecordswasconductedto
determineiftheseunusualnephrographicpatterns,compared
withexpectednonenhancingparenchymalattenuationat24-h
after TACE, were associated with contrast volume, contrast
type, ﬂuoroscopic/procedure time, tumor size, tumor type,
Fig. 1 Noncontrast CAT image at baseline and at 24 h after TACE in
a 76-year-old woman with hepatocellular carcinoma and cirrhosis. A
Baseline preprocedural noncontrast abdominal CAT having attenua-
tion values of 33.8 HU for the right renal parenchyma and 33.9 HU
for the left renal parenchyma. B Noncontrast CAT image in the same
patient 24 h after TACE shows globally dense bilateral nephrograms.
There is distinct demarcation of dense cortex and medulla as well as
vicarious excretion of contrast material in the gallbladder (small white
arrows). Right kidney cortical attenuation (black ROI) is 211.2 HU
and medullary attenuation (white ROI is 88.9 HU. Left kidney cortical
attenuation (black ROI) is 215.5 HU and medullary attenuation (white
ROI) is 87.9 HU
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and clinical criteria of bilirubin level, albumin level, pro-
thrombin time,degree ofascites, andhepaticencephalophy),
presence or absence of cirrhosis, baseline, SCr, estimated
GFR (eGFR; Modiﬁed Diet in Renal Disease estimation
equation)[10],andbaselineandperiproceduralmeanarterial
bloodpressuresatthetimeoftheTACEprocedure(Figs. 3,4,
Table 2).
An assessment was also made of the changes in SCr at
24 and 48 h after TACE, with subsets being those patients
with globally dense nephrograms, focally dense nephro-
grams, and the expected nonenhancing 24-h renal paren-
chymal attenuation (Fig. 4).
Statistical Analysis
We used the nonparametric tests of either two-sided Wil-
coxon–Mann–Whitney test for nonpaired or a two-sided
Wilcoxon signed-rank test for paired comparisons. To test
for associations between clinical parameters and the
occurrence of abnormal nephrograms on 24-h noncontrast
CAT scans, we used two-sided Wilcoxon–Mann–Whitney
test or two-sided Fisher’s exact test; p\0.05 was consid-
ered statistically signiﬁcant. All analyses were performed
using SAS (version 9.1) software (SAS Institute, Cary, NC).
Results
Overall, abnormal nephrograms were observed in 28 of 60
(46.7%) 24-h post-TACE nonenhanced CAT scans. Of
Fig. 2 Noncontrast CAT scan 24 h after TACE in a 54-year-old man
with insulinoma metastatic to the liver. Coronal (A) and axial (B)
CAT images showing a focally dense, wedge-shaped nephrogram
(arrows in both ﬁgures) in the lower pole of the right kidney
Fig. 3 Graph depicting baseline and 24-h renal attenuation (in HU)
for the combined versus the globally dense nephrogram groups. There
is no difference in renal parenchyma attenuation at baseline; however,
there is much greater cortical and medullary attenuation (p\0.0001
for each) at 24 h compared with parenchymal attenuation in the
combined group. Values shown are the means and SEMs
Fig. 4 Graph depicting changes in SCr from baseline (before TACE)
to 24- and 48-h after TACE in the globally dense nephrogram versus
combined nephrogram groups. The increase in SCr for the globally
dense group at 24 h after TACE was signiﬁcantly greater (p = 0.031)
than for the combined group. There was also a near statistical
difference at 48 h after TACE. Values shown are means and SEMs
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(23.3%) scans were focal. The expected parenchymal
ﬁndings were noted in 32 (53.3%) post-TACE CAT scans.
Focally dense nephrograms were noted unilaterally in
nine, bilaterally in ﬁve, and multiple (either bilateral or
unilateral) in seven scans. In contrast, attenuation values of
the uninvolved parenchyma were not statistically different
from the attenuation values of the baseline or 24-h non-
contrast ‘‘expected’’ values. Therefore, for statistical anal-
ysis, the ‘‘focal’’ parenchymal group values were combined
with the ‘‘expected’’ group values and termed the ‘‘com-
bined’’ group values.
Persistent bilateral globally dense cortical and medul-
lary nephrographic distinction was observed in 12 of 14
(85.7%) scans, and globally dense but indistinguishable
cortical and medullary enhancement was present in 2 of
14 (14.3%) scans. Because there was no statistical dif-
ference in right to left renal cortical or medullary atten-
uations, these values were combined, resulting in both
cortical and medullary attenuation averages derived from
24 kidneys.
On the nonenhanced, pre-TACE baseline scans, the
average attenuation value of the kidneys was 34.1 ± 4.1
HU (SD) in the combined cases and 36.7 ± 11.5 HU
(not signiﬁcant [NS]) in the cases that did have persis-
tent global nephrograms. On the 24-h post-procedure
scans, this average renal attenuation was 43.8 ± 6.1 HU
in the combined group, whereas those with bilateral
global dense nephrograms had cortical attenuation values
of 109.5 ? 43.9 HU (p\0.0001) and medullary values
of 72.5 ? 16.3 HU (p\0.0001) (Fig. 3). In the two
circumstances of bilateral globally dense nephrograms,
in which there was no distinct cortical and medullary
differentiation, the cortical and medullary parenchymal
attenuation values of the right kidney were 79.9 and
79.5 HU and of the left kidney were 79.3 and 89.6 HU,
respectively. These values are clearly greater than for
the combined group average of 43.8 ± 6.1 HU; how-
ever, the data set was too small to determine statistical
signiﬁcance.
With respect to the bilateral globally dense nephro-
grams, patients who had this ﬁnding after initial
chemoembolization also had this ﬁnding after each sub-
sequent procedure. Furthermore, dense nephrograms
were either always present or never present in each
patient. However, focal nephrograms were more sporadic
in their occurrence. Two patients had focal nephrograms
after the ﬁrst procedure but never had them subse-
quently, whereas ﬁve patients had focal nephrograms
only after their second or third chemoembolization. Five
of the patients had focal nephrograms after their ﬁrst and
only chemoembolization.
Clinical Factors Associated with Persistent Globally
Dense Nephrograms
When multiple clinical variables were assessed as they
occurred at each procedure, presence of cirrhosis (p =
0.03), ﬂuoroscopic/procedure time (p = 0.028), lower
baseline eGFR (p\0.001), Child-Pugh score B or C
(p B 0.001), and lower periprocedural mean arterial blood
pressure (p = 0.005) were signiﬁcantly associated with the
occurrence of bilateral globally dense nephrograms
(Table 2). There was no association with tumor burden
(p = 0.121; NS), contrast medium volume (p = 0.1239;
NS), contrast medium type (p = 0.311; NS), or vicarious
biliary excretion (p = 0.1141; NS). Cisplatinum is a
nephrotoxic chemotherapeutic agent, and a relatively high
dose of 100 mg was used in accordance with the com-
monly cited and used University of Pennsylvania protocol
for the chemoembolization chemotherapeutic regimen,
including cisplatin (100 mg), adriamycin (50 mg), and
mitomycin (10 mg). All patients received the same neph-
rotoxic drug regimen; thus, we could not correlate the use
of this chemotherapeutic with the imaging and clinical
ﬁndings described.
There was no statistically signiﬁcant difference in con-
trast volume used when comparing ﬁrst versus subsequent
procedures when dense nephrograms were detected (p =
0.5313) or when normal expected and focally dense
nephrograms were detected (p = 0.9332). Furthermore, the
type of contrast was not changed for subsequent procedures
Table 2 Variables associated with bilateral global nephrograms
versus expected nephrograms seen on noncontrast CAT obtained 24 h
after TACE
Parameters Combined
nephrogram
(observation)
Bilateral global
nephrogram
(observation)
p
Cirrhosis (yes/no) 24/22 12/2 0.03
Child-Pugh score
Noncirrhotic 22 2 B0.001
A1 1
B1 9 3
C4 8
MAP (mm Hg) 90.7 ± 13.2 79.6 ± 8.2 0.005
eGFR (mL/min)
baseline
91.6 ± 16.9 71.1 ± 19.3 \0.001
Tumor burden (cm)
a 15.2 ± 8.1 10.8 ± 3.7 0.12 (NS)
Fluoroscopic
time (min)
37.3 ± 22.0 60.0 ± 34.4 0.028
CM dose (mL) 213.5 ± 107 249.6 ± 86 p = 0.12 (NS)
Number of procedures = unit of statistical analysis
MAP mean arterial pressure
a Measured using the RECIST criteria
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cedure because there was never a large enough change in
creatinine after the ﬁrst procedure to warrant a change.
There was also no statistically signiﬁcant difference in
ﬂuoroscopy time when comparing the ﬁrst procedure, in
which dense nephrograms were present, with subsequent
procedures (p = 0.0625) or when normal expected and
focally dense nephrograms were detected (p = 0.9055).
We tested whether the focal nephrogram observation
was different from the expected nephrogram relative to
possible risk factors, such as catheter clotting or cholesterol
emboli. This was not directly determined but indirectly
suggested based on ﬂuoroscopy time and relative qualita-
tive assessment of atherosclerosis. A qualitative assessment
of atherosclerotic disease was made from the CAT
obtained before chemoembolization. The overall extent of
aortic renal and mesenteric arterial atherosclerotic disease
was subjectively graded as mild, moderate, or severe. Only
one patient with focal nephrograms had moderate aortic
and renal artery atherosclerotic disease; three patients had
mild atherosclerotic disease; and the remainder of the
patients had no aortic or renal atherosclerosis.
The occurrence of focal nephrographic patterns was
related to ﬂuoroscopic/procedure time (p = 0.029). How-
ever, focal nephrographic patterns were not associated with
extent of atherosclerotic disease of the aorta or the mes-
enteric or renal arteries. The kidney has a tubular con-
centrating function that is not present in other solid viscera,
such as the spleen, so it is not surprising that no other
viscera demonstrated these focal densities.
Relations Between CAT Nephrograms and Renal
Function
Baseline eGFR (mL/h) values were lower (71.1 ? 19.3 vs.
91.6 ? 16.9; p\0.001) in patients with persistent global
nephrograms compared with those not having persistent
global nephrograms. Baseline eGFR was determined on the
morning of each procedure, usually near the time peri-
procedural hydration was initiated.
There was no signiﬁcant difference in baseline, 24-h, or
48-h SCr values between the expected and focal nephro-
gram groups; thus, these data sets were combined. The 24-h
SCr had a signiﬁcantly higher (p = 0.031) increase from
baseline (1.00 ± 0.26–1.13 ± 0.24 mg/L) in the global
nephrogram group than in the combined nephrogram group
(0.87 ± 0.32–0.88 ± 0.3 mg/dL) (Fig. 4). Baseline creati-
nine and GFR were always recalculated before each pro-
cedure. Our database subsets were too small to determine if
baseline creatinine levels were different at each procedure.
In patients with dense nephrograms, there was no difference
in the degree of the change in creatinine when comparing
levels after the ﬁrst and subsequent procedures. However,
given our small sample size, statistical signiﬁcance could
not be determined.
In 93% (13 of 14) of the procedures yielding global
nephrograms and 41% (19 of 46) of procedures yielding
expected and focal nephrograms (combined), SCr was
determined 48 h after TACE. There was a near statistical
difference (p = 0.06) in the change of SCr from baseline
between the global and combined groups at 48 h (1.0 ±
0.26–1.2 ± 0.3 vs. 0.87 ± 0.32–0.94 ± 0.4, respectively).
Given that approximately one half of the expected and
focal groups did not undergo a 48-h SCr because they did
not require further periprocedural clinical observation for
postembolization syndrome, one might also have expected
a statistical difference if all subjects had received a 48-h
SCr measurement.
In two patients seen during follow-up, creatinine levels
remained slightly increased (1.1–1.4 and 0.9–1.0); in all
others seen during follow-up, creatinine levels returned to
baseline. One of the subjects who had globally dense
nephrograms seen on CAT after TACE became oliguric,
and nephrology consult was sought. This subject was
vigorously hydrated and subsequently improved without the
need for dialysis.
Discussion
We describe two types of delayed nephrographic patterns
seen on nonenhanced CAT obtained 24 h after TACE.
These observations were previously made only anecdotally
at our institution, and we elected to assess the incidence of
these ﬁndings by undertaking a systematic retrospective
review of our case material. We were somewhat surprised
by the relatively frequent occurrence (46.7% overall) of
these two types of nephrograms: Persistent, globally dense
nephrograms occurred after 14 of 60 (23.3%) TACE pro-
cedures and (2) wedge-like, focally persistent nephro-
grams, either single or multiple, occurred after 14 of 60
(23.3%) TACE procedures. A review of the medical
records was performed to determine if these unusual
nephrographic patterns are associated with ARF and any
speciﬁc patient clinical characteristics and/or periproce-
dural factors. Our intent was to investigate possible asso-
ciated factors for these unusual nephrographic patterns and
to assess the potential for clinical signiﬁcance, which might
warrant changes in periprocedural patient care.
Older et al. reported that 53% of patients who had
persistent renal parenchymal enhancement on plain radio-
graphs, which were obtained 24 h after angiography, had
documented ARF [1]. Love et al. described noncontrast
CAT scan images that demonstrated 24-h delayed cortical
enhancement [3]. In their investigation, measurements
averaging [140 HU were accompanied by clinical
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investigators also suggested that intermediate density lev-
els with persistent enhancement, ranging from 55 to 110
HU, represented a ‘‘subclinical decrease in renal function.’’
Their patients had a tendency to be elderly and to have
borderline chronic renal insufﬁciency. Jakobsen et al.
described a persistent increase in the attenuation of the
cortex, seen on CAT, which was attributed to pinocytosis
of CM molecules into the proximal tubular cells, with the
magnitude of the nonionic dimers being greater with than
that of the nonionic monomers [11].
For the nephrogram of ARF, Newhouse and Pﬁster
hypothesized that these persistent, dense nephrograms
occurred due to continued glomerular ﬁltration of CM in
association with diminished cortical perfusion, which is
similar to the physiology encountered in systemic hypo-
tension or intratubular obstruction [12]. Slowed intratubu-
lar ﬂow of the glomerular ﬁltrate and contrast medium
would be associated with increased reabsorption of sodium
and water, resulting in an increased concentration of the
CM molecules within the tubular lumen.
Clinical and procedural factors associated with the
bilateral global nephrograms in this investigation were
older patient age, presence of cirrhosis of the liver, low
baseline eGFR, decreased periprocedural systemic blood
pressure during or after hydration, and ﬂuoroscopic/pro-
cedure time for the performance of TACE (Table 2). We
cannot directly link CIN as the primary etiology. There was
no association with contrast volume or contrast type. At
times, contrast quantities may be higher than those
expected from an experienced interventional radiologist. At
our academic institution, some cases are performed by
fellows and senior residents under the direct guidance of
attending physicians with varying levels of experience
(range 2–28 years in practice).
The rate of CIN between iodixanol and iohexol, as
previously reported in a randomized double-blind, pro-
spective angiographic clinical study of at-risk subjects, [13]
was[8 times greater (3% vs. 26%) for the latter agent. We
found no difference in ARF occurrence when comparing
types of contrast. Because[30 different deﬁnitions of ARF
have been cited in the literature [14], we used the criterion
of a statistically signiﬁcant change in serum creatinine (the
accepted surrogate of renal function) compared with
expected values in the baseline patient cohort, as described
by Tepel et al. [15].
It is noteworthy that nearly all patients with globally
dense nephrograms were admitted for C48 h, whereas those
without globally dense nephrograms were usually dis-
charged within 24 h of the procedure. In all except one case,
this prolonged admission was required for management of
more severe chemoembolization syndrome, including
varying degrees of nausea, emesis, discomfort, chills, and
sweating. Management included continued hydration and
administration of antiemetics and analgesics. One of these
patients had a prolonged admission for renal insufﬁciency
and self-limited oliguria.
Admitted patients underwent daily laboratory testing,
including creatinine and liver function tests; thus, 48-h
creatinine values were available. We therefore suggest that
the globally dense nephrogram and renal injury may be
associated with chemoembolization syndrome, which in
turn is thought to be related to tumor ischemic injury and
cytolysis and subsequent release of mediators. This is
known to be a major reason for hospitalization after
chemoembolization [16]. Lueng et al. found postemboli-
zation syndrome to be associated with gallbladder emboli-
zation and dose administered and inversely related to
patients having had previous chemoembolization. We
hypothesize that postembolization syndrome may also be
related to renal injury.
Signiﬁcant changes in SCr occurred between baseline
and 24 h after TACE in subjects who had bilateral globally
dense nephrograms. There was a near statistically signiﬁ-
cant change at 48 h between groups as well. Only
approximately one half of the combined group received 48
SCrs because they were more often likely to be clinically
stable enough for discharge at 24 h. The baseline eGFR
was lower in the global nephrogram group than the com-
bined group, suggesting higher vulnerability to ARF.
We believe that the ﬁnding of delayed, globally dense
nephrograms is possibly a more sensitive indicator of renal
compromise than changes in SCr. Limitations of SCr as an
indicator of renal injury are well known [10]. In patients
with normal renal function, there must be at least a 50%
decrease in GFR before the SCr changes signiﬁcantly.
Furthermore, there is a delay in the occurrence of SCr
increases related to the timing of ARF. Shemesh et al.
demonstrated that endogenous creatinine is hypersecreted
progressively by remnant renal tubules in patients with
glomerular disease [17]. These investigators suggested that
use of creatinine as a marker of renal function in glomer-
ulopathic patients will result in ‘‘gross and unpredictable
overestimates of the GFR.’’
One of our patients developed oliguric renal failure that
required more aggressive clinical care and the involvement
of the Nephrology Service. This patient was vigorously
hydrated and subsequently improved without requiring
dialysis. However, recent reports in the nephrologic litera-
ture suggest that even modest transient changes in SCr may
signal an increased risk of adverse outcomes. For example,
a consecutive sampling of 19,982 adults admitted to an
urban academic medical center showed that modest changes
in SCr were signiﬁcantly associated with increased mor-
tality, length of hospital stay, and cost, even after adjust-
ment for age, sex, severity of illness, and chronic kidney
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dysfunction, as reﬂected by an increase in SCr (or, more
precisely, in eGFR) and/or albuminuria or trace proteinuria,
has a major impact on cardiovascular risk [19]. Our current
investigation is too limited to assess long-term outcome,
and the overwhelming medical condition, i.e., terminal
neoplastic disease, would be a major confounding factor in
determining this possibility in our patient population.
If he or she sees these unique nephrographic ﬁndings on
postchemoembolization CAT, the radiologist plays an
important role in the diagnosis of possible renal injury. The
ﬁnding of a persistent nephrogram may precede the devel-
opment of oliguria or a detectable increase in SCr, which
might warrant a signiﬁcant change in clinical care.
Aggressive hydration to establish a urinary output of at least
3 litres/24 h and close surveillance of clinical chemistries
have been recommended at the earliest suggestion of renal
insufﬁciency after tumoricidal therapies with suspected
tumor lysis syndrome [20]. Administration of allopurinol
before cytotoxic therapy has been recommended for pre-
vention of ARF associated with tumor lysis [21]. In our
study, however, the globally dense nephrograms were not
associated with higher tumor burden. We cannot substan-
tiate tumor lysis as a causative factor of ARF in our study.
We observed a statistically signiﬁcant association
between the dense nephrograms and the presence of cir-
rhosis and the severity of hepatic disease as indicated by
Child-Pugh classiﬁcation. This may be related to exacer-
bated hepatorenal syndrome. Hepatorenal syndrome is
deﬁned as renal failure in patients with severely compro-
mised liver function in the absence of clinical,laboratory, or
anatomic evidence of other causes of renal failure [21]. It
resembles prerenal failure but does not respond to volume
replacement. No speciﬁc treatment exists; management is
conservative; and prognosis is poor. Epstein et al. found
renal xenon washout patterns, suggesting that decreased
renal perfusion in cirrhotic patients with hepatorenal syn-
drome is secondary to active vasoconstriction and cortical
ischemia [22]. Possible mediators of vasoconstriction
include serotonin (5-hydroxytryptamine) and angiotensin. It
is possible that treatment with vasodilators may reverse
hepatorenal-associated failure and may have a role in these
patients when dense nephrograms are present on CAT after
chemoembolization.
Segmental, wedge-shaped nephrograms on delayed
imaging studies have only rarely been reported. Anecdotal
case reports were described by Ishikawa et al. in 1985
[4, 5], by Pazmino et al. in 1983 [6], by Braedel et al. in
1987 [23], and by Trueba-Arguinarena et al. in 1997 [24].
We found the occurrence of wedge-shaped nephrograms
in 14 of 60 (23.3%) noncontrast CAT scans obtained 24 h
after TACE. We did not ﬁnd an associated statistically
signiﬁcant change in SCr. We postulate that these wedge-
shaped nephrograms represent trapped CM in the tubular
lumen secondary to segmental perfusion deﬁcits, i.e., either
embolic events or segmental vasoconstriction. One candi-
date for the latter hypothesis is the release of endogenous
vasoconstrictors, such as angiotensin II. When CM is
administered during the TACE procedure, there is—as
usual—the initial development of bilateral global nephro-
grams. If embolic events occur during the catheterization
procedure, or if vasoactive endogenous hormones are lib-
erated, then segmental areas of the renal parenchyma may
contain trapped CM. The well-perfused parenchyma clears
the CM, which has a biologic half-time of approximately
1.5 h. However, in the areas with segmental ischemia, the
CM does not empty, and sodium and water continue to be
reabsorbed from the tubular lumen. This results in accen-
tuation of the focally ischemic regions compared with the
normal parenchyma, which has cleared the CM. Choles-
terol emboli have indeed been noted to occur during
angiographic procedures [25, 26]. Furthermore, clots can
form around a catheter during angiographic procedures.
Researchers have shown that angiographic techniques can
lead to the release of particles, presumably made up of bits
of clot and fatty plaque material, into the blood [26]. It has
also been reported that cholesterol emboli are a known
cause of ARF [25].
Our study is limited by our relatively small number of
patients and by numerous underlying clinical factors that
confounded the data. Review of the intraprocedural images
did not suggest iatrogenic or technical causes, such as
nontarget renal artery embolization during chemoemboli-
zation or cholesterol/atherosclerotic embolization, although
it may be impossible to entirely exclude this as possibly
occurring during the procedure or with retrospective
review of the angiographic images. We did not demonstrate
an association with the degree of aortic, mesenteric, or
renal artery atherosclerotic changes with either the focal or
diffuse dense nephrograms. Continued data collection from
a larger database of patients can help isolate these factors.
Assessing imaging ﬁndings in patients who have under-
gone different types of angiographic procedures, such as
coronary angiography, may help clarify the role of under-
lying hepatic disease and renal insufﬁciency versus other
factors, such as atherosclerotic vasculopathy, leading to
ischemic renal injury. Furthermore, animal models can be
used to elucidate the effect of renal emboli on subsequent
nephrographic patterns.
In conclusion, we describe two distinct patterns of per-
sistent delayed nephrograms in patients receiving noncon-
trast CAT scans 24 h after TACE. We suggest that these
observations could be sensitive indicators of alterations in
renal physiology and the occurrence of ARF. Furthermore,
the detection of these ﬁndings might warrant changes in
periprocedural and subsequent clinical care. One might
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lization, such as decreased use of nephrotoxic chemother-
apeutics and use of the described sodium bicarbonate
regimen, with subsequent close monitoring of urine output.
A low threshold for the consultation of the Nephrology
Service might be advocated. There has been interest in the
use of intrarenal fenoldopam, using the Benephit System
(Angiodynamics, Freemont, CA), for renal infusion therapy
after angiographic procedures in patients at risk for devel-
oping CIN [27]. Although this phenomenon is not thought
to represent CIN, patients with these ﬁndings who do
develop a clinically signiﬁcant decrease in renal function
might beneﬁt from this therapy. Recently, there has been
increasing use of doxorubicin drug-eluting beads (LC Bead;
Angiodynamics, Freemont, CA). Because no ethiodol is
used in this regimen, follow-up nonenhanced CAT is not
commonly performed on the day after chemoembolization;
thus, these ﬁndings would not be detected. Furthermore, it is
not known what effect altered pharmacokinetics and
decreased systemic chemotherapeutic will have on these
ﬁndings. Interventional and diagnostic radiologists should
be aware of these unique nephrographic ﬁndings on CAT
after TACE and their possible clinical implications.
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